Short answer: The Mental Health Parity and Addiction Equity Act requires group health plans that cover mental health and substance-use treatment to do so on terms no more restrictive than for medical and surgical care, including copays, visit limits, and prior-authorization rules.
MHPAEA doesn’t force a plan to cover mental health or substance-use disorder (MH/SUD) treatment, but if it does (and most must), it has to apply comparable terms. That means the financial requirements (copays, deductibles), quantitative limits (like visit caps), and non-quantitative limits (prior authorization, medical-necessity criteria, network adequacy) for MH/SUD can be no more restrictive than those applied to medical/surgical benefits.
The Consolidated Appropriations Act, 2021 added a requirement that plans perform and document a comparative analysis of their non-quantitative treatment limitations on request. (Some newer 2024 rule provisions are under a regulatory pause, but the core parity requirement and the CAA analysis remain in force.)
Sources
- Mental Health Parity and Addiction Equity Act; Consolidated Appropriations Act, 2021; Employee Benefits KB (Compliance, MHPAEA).
Content history
Originally published: June 16, 2026
Last reviewed: June 16, 2026